🇺🇸

Index Intelligence

· daily

Dow Jones 30 Stocks SEC Filings — October 13, 2026

Across the ten filings dated 2026-10-13, the Dow Jones 30 picture is one of resilient headline growth masking weakening underlying trends. Banks reported strong YoY top-line gains (Goldman Sachs net revenues +23% YoY; JPMorgan managed net revenue +8% YoY) but sharp QoQ declines in trading and investment banking (Goldman GBM -13% QoQ, FICC -24% QoQ; JPMorgan IB fees -8% QoQ). Healthcare showed the sharpest divergence: UnitedHealth's earnings from operations rose to $6.6B from $4.3B, but this was flattered by $610M of favorable prior-period reserve development and membership fell by roughly 1.2M across segments. Johnson & Johnson's GAAP EPS collapsed to $0.09 on a talc charge, while adjusted EPS fell 7.5% and STELARA imposed a ~690 bps drag on Innovative Medicine; management nonetheless raised full-year adjusted EPS guidance midpoint to $11.10. Capital return and governance items (P&G dividend of $1.0885, Merck board addition, insider tax withholdings at Cisco and NVIDIA) were routine and low-materiality. Net read: quality of earnings is the central question, and several headline beats rest on one-time or reserve items.

4 high priority 6 medium 10 total filings
· daily

S&P 500 Consumer Discretionary Sector SEC Filings — October 13, 2026

This digest covers a single Form 4 filing from Carvana Co. (CVNA), an S&P 500 Consumer Discretionary constituent, filed for the period ending 2026-10-13. The only enriched event is a Rule 10b5-1 plan sale by President, Special Projects Taira Thomas of 5,597 Class A shares at $65.00 (approximately $364K), leaving Thomas with 357,442 shares. Because the filing carries no period-over-period financials, guidance, capital allocation, or M&A data, no sector-level trend aggregation or cross-company comparison is possible from this stream today. The sentiment is classified as negative and materiality as 4/10, which reflects the modest dollar size and the pre-arranged nature of the sale rather than a material shift in conviction. Market implication: a routine plan-based insider sale is a weak signal on its own, and the investor takeaway is to monitor for additional filings rather than act on this one.

1 high priority 1 total filings
· daily

S&P 500 Healthcare Sector SEC Filings — October 13, 2026

Across the ten S&P 500 Healthcare filings, the dominant theme is a split between earnings-quality noise and genuine guidance strength. UnitedHealth and Johnson & Johnson both raised full-year EPS guidance, yet UNH's Q3 operating earnings were flattered by $610 million of favorable prior-period reserve development and J&J's GAAP EPS collapsed to $0.09 on a talc litigation charge, so headline numbers need to be stripped of one-offs before they are trusted. Volume and membership trends are weakening at the managed-care end: UNH revenue slipped to $112.7 billion from $113.2 billion, Optum Health revenue fell 10% YoY, and Medicare Advantage membership shrank by 935,000 since year-end 2025. Capital-structure and governance activity is heavy but largely procedural, including Humana's CenterWell joint venture restructuring that removes a WCAS put option, Medtronic's oversubscribed MiniMed exchange offer with an estimated 18.3% proration, and several board appointments at Zoetis, Merck and Danaher. Insider activity at Intuitive Surgical is limited to routine tax withholding on RSU vestings at $423.96 per share, which signals no material conviction either way. Overall the sector picture is one of guidance held or raised by the largest names, offset by reserve-driven and litigation-driven distortions that will matter for Q4 2026 comparisons.

7 high priority 3 medium 10 total filings
· daily

S&P 500 Technology Sector SEC Filings — October 09, 2026

Across the 10 newly reviewed S&P 500 technology filings for 2026-10-09, the dominant theme is heavy insider selling by senior executives, concentrated among software, networking, and semiconductor names: Arista's CEO disposed of roughly $15M plus two smaller tranches, Analog Devices' Chief Operations/Tech Officer sold about $2.2M across two transactions, Datadog's CTO sold about $5.05M after option exercises, and Accenture's COO sold about $264K. Most of these sales were executed under Rule 10b5-1 plans, which dampens the signal value of any single transaction, though the clustering across companies in a single session is worth monitoring. The one substantive financial filing is Micron's 10-K for the fiscal year ended September 3, 2026, which reports revenue of $133,188M versus $37,378M in FY2025 (up 256%), net income of $84,969M versus $8,539M, gross margin expanding to 81% from 40%, and operating cash flow of $89,675M versus $17,525M. Micron's effective tax rate rose to 14.8% from 11.6% and interest expense fell to $106M from $477M after several debt tranches were repaid, while management supported an increase in authorized share repurchases. Gifting activity at Palo Alto Networks and NVIDIA and a board appointment at Cisco are governance items with limited direct market impact. The Micron filing is the materiality outlier, and the insider-selling cluster is the main sentiment counterweight.

10 high priority 10 total filings
· daily

Nasdaq 100 Stocks SEC Filings — October 09, 2026

The 2026-10-09 NASDAQ-100 SEC filing stream is dominated by one standout fundamental report: Micron Technology's FY2026 10-K, which shows revenue of $133,188M (up 256% from $37,378M), net income of $84,969M versus $8,539M, gross margin expanding to 81% from 40%, and operating cash flow of $89,675M, supporting a larger buyback authorization. Balance sheet deleveraging is evident, with senior note repayments through 2026 and interest expense down to $106M from $477M, though the effective tax rate rose to 14.8% from 11.6%. The remaining filings are governance and insider-activity items: Cisco added independent director Girish Rishi (committee assignments pending), NVIDIA's director made a 500,000-share gift under a 10b5-1 plan, and Analog Devices' COO/CTO Vivek Jain sold roughly $2.2M of stock across two transactions. Strategy Inc's DEFA14A is an incomplete excerpt with no substantive content and is excluded from quantitative analysis. Portfolio-level, the signal set is semiconductor-heavy and points to strong AI-cycle earnings power alongside modest, largely routine insider selling.

4 high priority 1 medium 5 total filings
· daily

S&P 500 Financials Sector SEC Filings — October 09, 2026

The stream covers three SEC filings dated 2026-10-09, but only two fall within the S&P 500 Financials scope: AFLAC Inc. and Robinhood Ventures Fund I, both reporting Form 4 insider sales by 10% owners. Both sets of sales were executed under Rule 10b5-1 plans, which reduces their informational weight as signals of management conviction. AFLAC's 10% holder Japan Post Holdings sold roughly $1.35M at $112.80 plus a small $4.54K tranche, leaving it with 50.38M shares, so the disposal is modest relative to its stake. Robinhood Markets sold about $353K across two tranches in Robinhood Ventures Fund I, leaving 12.96M shares. The third filing, a Morgan Stanley Capital I Trust 2016-UBS11 Form 15, is an asset-backed trust termination and is outside the S&P 500 Financials constituent list. Period-over-period comparisons and forward-looking guidance were not present in the enriched data for these filings, so no quantitative YoY/QoQ trend or catalyst can be drawn. The dominant theme is 10b5-1 monetization by large holders, with no evidence of broader sector stress or guidance revisions in this batch.

3 high priority 3 total filings
· daily

S&P 500 Consumer Staples Sector SEC Filings — October 09, 2026

This Consumer Staples stream covers only two newly published filings for the 2026-10-09 window: a Hershey Form 4 showing continued 10b5-1 selling by the Hershey Trust, and an Altria 8-K extending its $3.0 billion revolving credit facility. Neither filing carries the period-over-period financial comparisons, guidance, or margin data the enriched schema promises, so portfolio-level trend analysis is not possible from this batch. The Hershey activity is the more market-relevant item: a 10% holder trust sold roughly 8,075 shares at about $162.42 (~$1.31M) across seven transactions, reducing its position to 616,119 shares, though the sales are pre-planned and the trust's selling is a structural diversification pattern rather than a directional call. The Altria amendment is administrative, pushing maturity from October 2029 to October 2030 with unchanged terms, signaling continued access to committed liquidity rather than any stress. Overall the batch offers limited actionable signal, and investors should treat the Hershey sales as a sentiment marker rather than a thesis change.

2 high priority 2 total filings
· daily

S&P 500 Industrials Sector SEC Filings — October 09, 2026

Six filings were reviewed for the USA S&P 500 Industrials stream; all six fall within scope. Delta Air Lines dominates the period: its September quarter 10-Q and 8-K show revenue growth of 21% YoY (GAAP) but operating margin compression to 7.2% from 10.1%, net income down 46.6%, and adjusted EPS of $1.72 flat YoY, as fuel prices rose 60% YoY to $3.61 per gallon and non-fuel unit costs rose 7.3%. Management guided Q4 2026 EPS to $1.15-$1.65 and full-year 2026 EPS to $5.10-$5.60 with roughly $2.5 billion of free cash flow, while nine-month operating cash flow fell 5.6% to $5,740 million. Delta's total debt and finance leases declined to $12,851 million from $14,112 million at year-end 2025, but current maturities rose to $3,324 million from $1,605 million, a near-term refinancing item to monitor. Premium and loyalty revenues (+18% each) are the clearest positive signals, indicating pricing power in the diversified revenue base. At 3M, four insider filings reflect routine equity vesting, tax withholding and option exercises at $162.12 per share by the CTO, Group President, and Chief Legal Officer, with no open-market selling evident; the implied insider sentiment is neutral. Norfolk Southern's only filing is a director's inheritance of 333.33 shares, which carries no signal. Overall the period is dominated by airline cost pressure, with fuel and labor costs offsetting strong top-line demand.

5 high priority 1 medium 6 total filings
· daily

Dow Jones 30 Stocks SEC Filings — October 09, 2026

This Dow Jones 30 digest covers six SEC filings dated October 9, 2026, five newly published and one carried forward for context. Five of the six are insider or governance disclosures from 3M, Walt Disney, NVIDIA and Cisco, and the set contains no reported period-over-period financial results, so there are no revenue, margin or guidance trend comparisons to synthesize. The dominant theme is routine executive equity compensation activity at 3M, where three officers exercised or had shares withheld for taxes at the same $162.12 price, which suggests scheduled vesting rather than a directional view. Disney's EVP Woodford sold $381K of stock under a 10b5-1 plan, a modest negative signal given the plan structure. NVIDIA's director gift of 500,000 shares and Cisco's board appointment of Girish Rishi are governance events with limited near-term market impact. Overall, the filings offer little actionable alpha; the most useful takeaway is that insider activity at 3M is uniform and non-discretionary-looking, while the Disney sale is the only transaction carrying a mild bearish read.

6 high priority 6 total filings
· daily

S&P 500 Consumer Discretionary Sector SEC Filings — October 09, 2026

This stream window contains a single filing from AutoZone, Inc. (AZO), an S&P 500 Consumer Discretionary constituent within scope. The 8-K discloses that director Claire R. McDonough informed the Board on October 6, 2026 that she will not stand for reelection at the 2026 Annual Meeting, citing a new executive role at another company whose calendar conflicts with future AutoZone board meetings. The filing explicitly states the decision was unrelated to any disagreement on operations, policies, or practices, and the Board said it would have preferred a different outcome. The filing carries a low materiality score of 3/10 and neutral sentiment. No period-over-period financials, forward-looking guidance, insider trading activity, capital allocation actions, or transaction details were included in the enriched data, so cross-company comparisons and quantitative trend analysis are not possible for this window. The implication is governance-housekeeping rather than fundamental: the event is a planned board turnover, not a distress signal. Investors should treat this as routine unless it is followed by a broader board refresh or disagreement disclosure.

1 high priority 1 total filings
· daily

S&P 500 Healthcare Sector SEC Filings — October 09, 2026

Four SEC filings were reviewed for the USA S&P 500 Healthcare stream, all dated October 9, 2026. Three of the four are in scope: Humana (8-K), Medtronic (two Rule 425 filings), and Cigna Group (8-K). The dominant development is Humana's disclosure that its 2027 Medicare Advantage Star Ratings (Bonus Year 2028) exceed its Top Quartile goal, with management affirming FY 2026 Adjusted EPS guidance of at least $9.00 and signaling that part of the BY28 outperformance will be one-time and redeployed into investments and shareholder returns. Medtronic's filings describe an exchange offer for up to 225,361,295 MiniMed Group shares in exchange for Medtronic common stock as part of a MiniMed separation, but neither filing discloses an exchange ratio, valuation, or financial results, so the market impact cannot yet be sized. Cigna's 8-K is a routine board retirement with no financial implications. The provided enriched data contains no period-over-period financial comparisons, insider transaction records, capital allocation figures, or ratio data, so trend-based synthesis across peers is not supportable from these filings and conclusions are limited to disclosed events and guidance language.

3 high priority 1 medium 4 total filings
· daily

S&P 500 Technology Sector SEC Filings — October 08, 2026

All five filings in this digest are Form 4 insider transaction reports from S&P 500 Technology constituents (Analog Devices, Apple, Arista Networks, CrowdStrike), covering a single filing date of 2026-10-08. Every filing is classified negative, and every reported sale was executed under a Rule 10b5-1 pre-arranged trading plan, which substantially reduces the informational signal of the selling. The aggregate notional value is roughly $57M, driven almost entirely by Arista Networks CEO Jayshree Ullal (~$55M across 9 transactions), with CrowdStrike CEO George Kurtz (~$1.06M in the reported sale, 21 transactions in total), Analog Devices director Ray Stata (~$295K in the reported sale, 11 transactions in total), Apple SVP Jennifer Newstead (~$796K) and Arista CFO Chantelle Breithaupt (~$263K) making up the rest. The filings do not include period-over-period financial comparisons, guidance, capital allocation, or M&A data, so trend analysis of revenue, margins or balance sheet is not possible from this set. The dominant pattern is routine, plan-driven liquidity selling by senior executives and a director at companies whose shares were trading in the $212 to $420 range at the time of the sales. Given that the sales are concentrated in one pre-arranged 10b5-1 cohort, the market-implication read is limited, though Arista's scale of disposal relative to its CEO's holding is the single most material item.

4 high priority 1 medium 5 total filings
· daily

Nasdaq 100 Stocks SEC Filings — October 08, 2026

Six SEC filings were reviewed for the NASDAQ-100 stream, with PepsiCo supplying the bulk of material signal (two filings, both materiality 9/10) and three insider-trading Form 4s from Analog Devices, CoreWeave and Apple providing a read on management activity. PepsiCo's Q3 2026 shows top-line strength (net revenue +5.6% YoY to $25.274B, organic +3.1%, EPS +17% YoY) but deteriorating profitability quality: core operating margin contracted 35 bps to 16.9% and core EPS grew only ~2%, prompting a sharp cut to full-year core EPS guidance from +5-7% to +2.5-3.5%. Year-to-date results look strong on a reported basis (net income +46.6% to $8.356B, operating cash flow $7.950B vs $5.468B), but a $858M currency translation loss and a jump in financing outflows to $3.904B from $1.008B warrant scrutiny. Insider activity across the set was modest and largely routine: sales executed under Rule 10b5-1 plans at Analog Devices (director, ~$295K tranche, 107,431 shares retained), Apple (SVP/GC, ~$796K at $332.01) and CoreWeave (CFO, trivial $266 sale), with CoreWeave's director activity being exercise/RSU conversion rather than open-market selling. The portfolio-level read is a mix of resilient reported earnings and softening underlying margin and guidance, with no evidence of a broad insider exodus.

4 high priority 2 medium 6 total filings
· daily

S&P 500 Financials Sector SEC Filings — October 08, 2026

This digest covers five SEC filings dated October 8, 2026, but only three fall within the S&P 500 Financials scope: American Express (8-K), Aflac (Form 4), and Capital One's Multi-asset Execution Trust (8-K). The Robinhood Ventures Fund I filings (DEF 14A and DEFA14A) concern a fund vehicle outside the fixed list of 34 index constituents and are excluded. The enriched data for the in-scope filings is thin: no period-over-period financial comparisons, forward-looking metrics, or ratio data were supplied, so trend analysis is limited. The most material development is American Express's consent orders with the Federal Reserve and OCC, including a $350 million OCC civil money penalty, partly reserved in prior periods, with management stating full-year 2026 guidance and 2027 guidance are not affected. Aflac's insider activity shows a 10% owner, Japan Post Holdings, selling roughly $1.5 million of stock under a Rule 10b5-1 plan, a routine-looking but directionally negative signal. Capital One's ABS issuance is a routine funding event with a transferor interest of about 74% and no disclosed credit deterioration. Overall, the in-scope signals are regulatory and ownership-driven rather than fundamental, and no sector-wide pattern can be drawn from this small sample.

2 high priority 3 medium 5 total filings
· daily

S&P 500 Energy Sector SEC Filings — October 08, 2026

Three SEC filings from the S&P 500 Energy stream were reviewed for the single-day period of October 8, 2026, two of them newly published. The dominant theme is commodity-price-driven: EOG Resources raised its Q3 2026 current tax expense guidance to $835-935 million from $545-645 million, citing higher crude prices (Q3 average WTI $85.68/bbl) tied to the ongoing Middle East conflict, while Henry Hub averaged $2.95/MMBtu. Devon Energy's agreement to sell Eagle Ford assets to Crescent Energy for $4.2 billion in cash is the most material development (materiality 9/10), with closing targeted for Q4 2026 or early 2027 and proceeds earmarked for share repurchases and debt reduction. Texas Pacific Land's pending Delaware-to-Texas redomestication vote on November 5, 2026 is a governance event rather than a financial one, though it bears on shareholder-rights terms. Filing-level period comparisons (YoY/QoQ production, margin, and balance-sheet figures) were not supplied in the enriched data for these three filings, so portfolio-level growth or margin trend claims cannot be quantified from this set and should be treated as a limitation. Overall sentiment is mixed-to-neutral, with upside from higher realized commodity prices offset by execution and deal-closing uncertainty.

3 medium 3 total filings
· daily

S&P 500 Consumer Staples Sector SEC Filings — October 08, 2026

Across the six filings, the dominant theme is a sharp divergence between PepsiCo's top-line/cash-flow strength and its deteriorating earnings quality outlook. PepsiCo's Q3 2026 net revenue rose 5.6% YoY to $25.274B and year-to-date revenue rose 6.7% to $68.898B, while year-to-date net income attributable to PepsiCo jumped 46.6% to $8.356B, aided by the absence of prior-year impairments. However, core operating margin contracted 35 bps to 16.9%, core EPS growth slowed to just 2%, and full-year core EPS guidance was cut from +5-7% to +2.5-3.5% on input cost inflation, implying the market should weigh guidance heavily over reported headline gains. Operating cash flow improved sharply to $7.950B from $5.468B, but financing outflows rose to $3.904B from $1.008B and a $858M currency translation loss (versus a $39M gain a year ago) flags FX headwinds. The four Walmart filings are routine Form 4 tax-withholding transactions at $105.07 per share totaling roughly $89K across four executives, with no open-market buying or selling signal and no meaningful conviction read-through. Overall the stream points to a consumer staples name whose reported growth is strong but whose forward margin trajectory and cost-inflation exposure now warrant closer scrutiny.

5 high priority 1 medium 6 total filings
· daily

S&P 500 Industrials Sector SEC Filings — October 08, 2026

This digest covers two S&P 500 Industrials filings dated 2026-10-08: a General Dynamics 8-K announcing a CEO succession and a Form 4 from Trane Technologies showing a sizable insider sale by its Chair and CEO. Both are in scope (aerospace/defense and building technologies/HVAC within the fixed index-constituent list). The General Dynamics filing is a planned, orderly leadership transition: Danny Deep, a 25-year company veteran and current president since 2025, succeeds Phebe Novakovic as CEO effective January 1, 2027, with Novakovic moving to executive chairman after serving as CEO since 2013. The enriched data for this filing does not include period-over-period financial comparisons, guidance changes, or insider holdings, so the signal set is limited to the succession itself and the scale of the business ($52.6B 2025 revenue, 120,000+ employees). Trane's Form 4 is the more material item, with Chair and CEO David Regnery exercising options and selling 48,091 shares at $480.00 (~$23.1M) under a Rule 10b5-1 plan, leaving him with roughly 96,951 shares. Because the sale executes under a pre-set 10b5-1 plan, it is weaker evidence of a change in conviction than an open-market sale would be, but the size and the CEO role keep it notable. Neither filing contains enriched period-over-period, capital allocation, or M&A data, so cross-company comparisons are not possible this cycle.

2 high priority 2 total filings
· daily

Dow Jones 30 Stocks SEC Filings — October 08, 2026

Six SEC filings were received for the Dow Jones Industrial Average stream dated 2026-10-08, but the enriched data supplied is thin: none of the filings carries the period-over-period comparisons, forward-looking guidance tables, capital allocation figures, transaction valuations, or financial ratios that the Phase 1 enhancements were meant to provide. What is available covers one material regulatory event at American Express (consent orders with a $350 million OCC civil money penalty, with management stating full-year 2026 and 2027 guidance is unaffected) and a cluster of routine Form 4 insider filings at Walmart and Apple. The Walmart filings are tax-withholding transactions on vesting awards at $105.07 per share across four executives, totaling roughly $89K, and are neutral in signal value. The Apple filing is a 10b5-1 plan sale of about $796K by an SVP at $332.01, which is modestly negative in tone but immaterial relative to insider holdings. Because the data lacks quantitative trend analysis, portfolio-level growth and margin conclusions cannot be responsibly drawn; the digest therefore emphasizes the regulatory development and flags the data gaps.

4 high priority 2 medium 6 total filings
· daily

S&P 500 Consumer Discretionary Sector SEC Filings — October 08, 2026

All six filings originate from a single issuer, MGM Resorts International (Form 4 insider transaction reports), which places the stream's content squarely within the Consumer Discretionary casino/hotel/entertainment focus and index constituent scope. The filings are routine equity-compensation events: on the same reporting window, five executives and the CEO had restricted stock units (RSUs) vest and convert into common stock at a reference price of $30.00, with a portion of each grant withheld to cover tax obligations. Total withholding values range from roughly $10.1K (SVP & Chief Accounting Officer Meinert Todd) to about $383K (CEO William Hornbuckle), with the CEO's transaction the only one tagged at materiality 6/10 given its size. No open-market purchases or sales were reported; all dispositions were tax-withholding events, and sentiment across all six is neutral. Period-over-period comparisons, forward-looking guidance, capital allocation, financial ratios, and transaction valuation data were not present in these filings, so trend, margin, and guidance synthesis is not possible from this set. The dominant market implication is limited: the filings reflect standard executive compensation mechanics rather than a change in management conviction, though the cluster of same-date vestings across the C-suite is a pattern worth noting for context.

6 high priority 6 total filings
· daily

S&P 500 Healthcare Sector SEC Filings — October 08, 2026

Six S&P 500 healthcare filings from October 8, 2026 point to a corporate-action-heavy session dominated by Medtronic's split-off of MiniMed, with the final exchange ratio of 4.5939 MiniMed shares per Medtronic share set and the offer expiring October 9, 2026. Medtronic's two Rule 425/SC TO-I filings together represent the highest-materiality developments in the set, with the offer covering up to 225,361,295 MiniMed shares (80.1% of MiniMed's outstanding shares) and potential oversubscription of an additional 27,452,053 shares. Capital structure housekeeping was also visible: Centene is fully redeeming its remaining $568.7M 4.25% 2027 Notes on October 23, 2026 at par plus accrued interest, eliminating a near-term maturity without new financing. Shareholder-return signals were routine, with Zoetis declaring a $0.53 quarterly dividend (record October 30, payable December 1, 2026). Insider activity was limited to a single Edwards Lifesciences TAVR executive's 10b5-1 sale of 619 shares at $85.65 (~$53K), retaining roughly 40,034 shares. The filings contain no period-over-period revenue, margin, or guidance data, so trend analysis is constrained; the market implication centers on MiniMed separation mechanics, debt reduction, and dividend continuity rather than operating performance.

4 high priority 2 medium 6 total filings